Elissa M Malkin
Overview
Explore the profile of Elissa M Malkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
776
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diemert D, Zumer M, Bova M, Gibbs-Tewary C, Malkin E, Campbell D, et al.
PLoS Negl Trop Dis
. 2025 Jan;
18(12):e0012788.
PMID: 39775205
Background: Recombinant Necator americanus Glutathione-S-Transferase-1 (Na-GST-1) formulated on Alhydrogel (Na-GST-1/Alhydrogel) is being developed to prevent anemia and other complications of N. americanus infection. Antibodies induced by vaccination with recombinant Na-GST-1...
2.
Wu Y, Ellis R, Shaffer D, Fontes E, Malkin E, Mahanty S, et al.
PLoS One
. 2008 Jul;
3(7):e2636.
PMID: 18612426
Background: Pfs25 and Pvs25, surface proteins of mosquito stage of the malaria parasites P. falciparum and P. vivax, respectively, are leading candidates for vaccines preventing malaria transmission by mosquitoes. This...
3.
Dicko A, Diemert D, Sagara I, Sogoba M, Niambele M, Assadou M, et al.
PLoS One
. 2007 Oct;
2(10):e1045.
PMID: 17940609
Background: Apical Membrane Antigen 1 (AMA1) of Plasmodium falciparum merozoites is a leading blood-stage malaria vaccine candidate. Protection of Aotus monkeys after vaccination with AMA1 correlates with antibody responses. Study...
4.
Malkin E, Diemert D, McArthur J, Perreault J, Miles A, Giersing B, et al.
Infect Immun
. 2005 May;
73(6):3677-85.
PMID: 15908397
Apical membrane antigen 1 (AMA1), a polymorphic merozoite surface protein, is a leading blood-stage malaria vaccine candidate. A phase 1 trial was conducted with 30 malaria-naive volunteers to assess the...
5.
Malkin E, Durbin A, Diemert D, Sattabongkot J, Wu Y, Miura K, et al.
Vaccine
. 2005 Apr;
23(24):3131-8.
PMID: 15837212
Plasmodium vivax is responsible for the majority of malaria cases outside of Africa, and results in substantial morbidity. Transmission blocking vaccines are a potentially powerful component of a multi-faceted public...
6.
Kublin J, Dzinjalamala F, Kamwendo D, Malkin E, Cortese J, Martino L, et al.
J Infect Dis
. 2002 Jan;
185(3):380-8.
PMID: 11807721
Molecular assays for monitoring sulfadoxine-pyrimethamine-resistant Plasmodium falciparum have not been implemented because of the genetic and statistical complexity of the parasite mutations that confer resistance and their relation to treatment...